Pharmaceutical company Aurobindo Pharma USA, Inc. has voluntary recalled 80 lots of a blood pressure medication due to trace amounts of an impurity.
N-notrosodiethylamine (NDEA) is a substance that occurs naturally in some foods, air pollution and industrial processes and has been classified as a probable human carcinogen by the Internatinoal Agency for Research on Cancer.
Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP are all prescribed medications that help control blood pressure or treat heart failure.
These tablets were distributed nationwide.
Those taking the recalled drugs should continue the use of the medication as health risks might be increased if the medication is stopped right away.
Patients are encouraged to contact their physician to discuss possible alternative treatments.
Aurobindo Pharma USA, Inc. is contacting all distributors and customers in writing and by phone to discontinue distribution of specific lots of the drugs.
Medical questions regarding this product or those wanting to report an event can contact Aurobindo Pharma at 1-866-850-2876 Option 2.
For a full list of recalled products and lot numbers click here.